<VariationArchive VariationID="1451521" VariationName="NM_000466.3(PEX1):c.56_80del (p.Val19fs)" VariationType="Deletion" Accession="VCV001451521" Version="7" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-03-05" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1425923" VariationID="1451521">
      <GeneList>
        <Gene Symbol="LOC129998796" FullName="ATAC-STARR-seq lymphoblastoid silent region 18372" GeneID="129998796" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7q21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="92528349" stop="92528578" display_start="92528349" display_stop="92528578" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="PEX1" FullName="peroxisomal biogenesis factor 1" GeneID="5189" HGNC_ID="HGNC:8850" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7q21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="92487025" stop="92528520" display_start="92487025" display_stop="92528520" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="92116336" stop="92157844" display_start="92116336" display_stop="92157844" Strand="-" />
          </Location>
          <OMIM>602136</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000466.3(PEX1):c.56_80del (p.Val19fs)</Name>
      <CanonicalSPDI>NC_000007.14:92528355:CAGTCGCGAGCGTTGGTGAAGGCCACAGTC:CAGTC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="92528356" stop="92528380" display_start="92528356" display_stop="92528380" variantLength="25" positionVCF="92528355" referenceAlleleVCF="GCAGTCGCGAGCGTTGGTGAAGGCCA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="92157670" stop="92157694" display_start="92157670" display_stop="92157694" variantLength="25" positionVCF="92157669" referenceAlleleVCF="GCAGTCGCGAGCGTTGGTGAAGGCCA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>V19fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.92157675_92157699del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.92157675_92157699del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.92528361_92528385del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.92528361_92528385del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008341.2" sequenceAccession="NG_008341" sequenceVersion="2" change="g.5152_5176del">
            <Expression>NG_008341.2:g.5152_5176del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000466.3" sequenceAccession="NM_000466" sequenceVersion="3" change="c.56_80del" MANESelect="true">
            <Expression>NM_000466.3:c.56_80del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000457.1" sequenceAccession="NP_000457" sequenceVersion="1" change="p.Val19fs">
            <Expression>NP_000457.1:p.Val19fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282677.2" sequenceAccession="NM_001282677" sequenceVersion="2" change="c.56_80del">
            <Expression>NM_001282677.2:c.56_80del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269606.1" sequenceAccession="NP_001269606" sequenceVersion="1" change="p.Val19fs">
            <Expression>NP_001269606.1:p.Val19fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282678.2" sequenceAccession="NM_001282678" sequenceVersion="2" change="c.-604_-580del">
            <Expression>NM_001282678.2:c.-604_-580del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000466.2" sequenceAccession="NM_000466" sequenceVersion="2" change="c.56_80del25">
            <Expression>NM_000466.2:c.56_80del25</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1793398751" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000466.3(PEX1):c.56_80del (p.Val19fs) AND Zellweger spectrum disorders" Accession="RCV002007262" Version="3">
        <ClassifiedConditionList TraitSetID="55427">
          <ClassifiedCondition DB="MedGen" ID="C0043459">Zellweger spectrum disorders</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000466.3(PEX1):c.56_80del (p.Val19fs) AND multiple conditions" Accession="RCV002497861" Version="1">
        <ClassifiedConditionList TraitSetID="35335">
          <ClassifiedCondition DB="MedGen" ID="C4551980">Heimler syndrome 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4721541">Peroxisome biogenesis disorder 1A (Zellweger)</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0282527">Peroxisome biogenesis disorder 1B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-07-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000466.3(PEX1):c.56_80del (p.Val19fs) AND Peroxisome biogenesis disorder" Accession="RCV002509727" Version="1">
        <ClassifiedConditionList TraitSetID="7944">
          <ClassifiedCondition DB="MedGen" ID="C1832200">Peroxisome biogenesis disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-12-08" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000466.3(PEX1):c.56_80del (p.Val19fs) AND Heimler syndrome 1" Accession="RCV003475203" Version="1">
        <ClassifiedConditionList TraitSetID="23229">
          <ClassifiedCondition DB="MedGen" ID="C4551980">Heimler syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-10" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-09-10" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16086329</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16141001</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21031596</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26387595</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31831025</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9398847</ID>
        </Citation>
        <DescriptionHistory Dated="2023-01-15">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="55427" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="52389" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Zellweger syndrome</ElementValue>
                <XRef ID="912" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Zellweger Spectrum Disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Zellweger Spectrum</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Zellweger spectrum disorders</ElementValue>
                <XRef ID="MONDO:0019609" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ZS</ElementValue>
                <XRef Type="MIM" ID="214100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ZWS</ElementValue>
                <XRef Type="MIM" ID="214100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7917" />
                <XRef ID="7917" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2023">
                <URL>https://www.acmg.net/PDFLibrary/X-ALD-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated lysophosphatidylcholines, X-Linked Adrenoleukodystrophy (X-ALD), 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2023">
                <URL>https://www.acmg.net/PDFLibrary/X-ALD-Algorithm.pdf</URL>
                <CitationText>ACMG Algorithm, X-ALD: Elevated lysophosphatidylcholines C24:0, C26:0, 2023</CitationText>
              </Citation>
              <XRef ID="912" DB="Orphanet" />
              <XRef ID="C0043459" DB="MedGen" />
              <XRef ID="MONDO:0019609" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="35335" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5138" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Zellweger leukodystrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Peroxisome biogenesis disorder 1a</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 1A (Zellweger)</ElementValue>
                <XRef ID="MONDO:0008953" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PBD1A</ElementValue>
                <XRef Type="MIM" ID="214100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CHR</ElementValue>
                <XRef Type="MIM" ID="214100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Zellweger spectrum disorder (ZSD) is a phenotypic continuum ranging from severe to mild. While individual phenotypes (e.g., Zellweger syndrome [ZS], neonatal adrenoleukodystrophy [NALD], and infantile Refsum disease [IRD]) were described in the past before the biochemical and molecular bases of this spectrum were fully determined, the term "ZSD" is now used to refer to all individuals with a defect in one of the ZSD-PEX genes regardless of phenotype. Individuals with ZSD usually come to clinical attention in the newborn period or later in childhood. Affected newborns are hypotonic and feed poorly. They have distinctive facies, congenital malformations (neuronal migration defects associated with neonatal-onset seizures, renal cysts, and bony stippling [chondrodysplasia punctata] of the patella[e] and the long bones), and liver disease that can be severe. Infants with severe ZSD are significantly impaired and typically die during the first year of life, usually having made no developmental progress. Individuals with intermediate/milder ZSD do not have congenital malformations, but rather progressive peroxisome dysfunction variably manifest as sensory loss (secondary to retinal dystrophy and sensorineural hearing loss), neurologic involvement (ataxia, polyneuropathy, and leukodystrophy), liver dysfunction, adrenal insufficiency, and renal oxalate stones. While hypotonia and developmental delays are typical, intellect can be normal. Some have osteopenia; almost all have ameleogenesis imperfecta in the secondary teeth.</Attribute>
                <XRef ID="NBK1448" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301621</ID>
                <ID Source="BookShelf">NBK1448</ID>
              </Citation>
              <XRef ID="C4721541" DB="MedGen" />
              <XRef ID="MONDO:0008953" DB="MONDO" />
              <XRef Type="MIM" ID="214100" DB="OMIM" />
            </Trait>
            <Trait ID="5227" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PEROXISOME BIOGENESIS DISORDER 1C</ElementValue>
                <XRef Type="MIM" ID="234580" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Heimler syndrome 1</ElementValue>
                <XRef ID="MONDO:0024544" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HMLR1</ElementValue>
                <XRef Type="MIM" ID="234580" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PBD1C</ElementValue>
                <XRef Type="MIM" ID="234580" DB="OMIM" />
              </Symbol>
              <XRef ID="3220" DB="Orphanet" />
              <XRef ID="C4551980" DB="MedGen" />
              <XRef Type="MIM" ID="234580" DB="OMIM" />
            </Trait>
            <Trait ID="17738" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Refsum disease, infantile form</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Infantile Refsum disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Infantile form of phytanic acid storage disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 1B</ElementValue>
                <XRef ID="MONDO:0011101" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PBD1B</ElementValue>
                <XRef Type="MIM" ID="601539" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IRD</ElementValue>
                <XRef ID="GTR000518899" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Zellweger spectrum disorder (ZSD) is a phenotypic continuum ranging from severe to mild. While individual phenotypes (e.g., Zellweger syndrome [ZS], neonatal adrenoleukodystrophy [NALD], and infantile Refsum disease [IRD]) were described in the past before the biochemical and molecular bases of this spectrum were fully determined, the term "ZSD" is now used to refer to all individuals with a defect in one of the ZSD-PEX genes regardless of phenotype. Individuals with ZSD usually come to clinical attention in the newborn period or later in childhood. Affected newborns are hypotonic and feed poorly. They have distinctive facies, congenital malformations (neuronal migration defects associated with neonatal-onset seizures, renal cysts, and bony stippling [chondrodysplasia punctata] of the patella[e] and the long bones), and liver disease that can be severe. Infants with severe ZSD are significantly impaired and typically die during the first year of life, usually having made no developmental progress. Individuals with intermediate/milder ZSD do not have congenital malformations, but rather progressive peroxisome dysfunction variably manifest as sensory loss (secondary to retinal dystrophy and sensorineural hearing loss), neurologic involvement (ataxia, polyneuropathy, and leukodystrophy), liver dysfunction, adrenal insufficiency, and renal oxalate stones. While hypotonia and developmental delays are typical, intellect can be normal. Some have osteopenia; almost all have ameleogenesis imperfecta in the secondary teeth.</Attribute>
                <XRef ID="NBK1448" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301621</ID>
                <ID Source="BookShelf">NBK1448</ID>
              </Citation>
              <XRef ID="44" DB="Orphanet" />
              <XRef ID="C0282527" DB="MedGen" />
              <XRef ID="MONDO:0011101" DB="MONDO" />
              <XRef Type="MIM" ID="601539" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="23229" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5227" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PEROXISOME BIOGENESIS DISORDER 1C</ElementValue>
                <XRef Type="MIM" ID="234580" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Heimler syndrome 1</ElementValue>
                <XRef ID="MONDO:0024544" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HMLR1</ElementValue>
                <XRef Type="MIM" ID="234580" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PBD1C</ElementValue>
                <XRef Type="MIM" ID="234580" DB="OMIM" />
              </Symbol>
              <XRef ID="3220" DB="Orphanet" />
              <XRef ID="C4551980" DB="MedGen" />
              <XRef Type="MIM" ID="234580" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7944" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5752" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PEROXISOME BIOGENESIS DISORDER (NEONATAL ADRENOLEUKODYSTROPHY/INFANTILE REFSUM DISEASE)</ElementValue>
                <XRef Type="MIM" ID="601539" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INFANTILE PHYTANIC ACID STORAGE DISEASE</ElementValue>
                <XRef Type="MIM" ID="601539" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder</ElementValue>
                <XRef ID="INHP_50" DB="Ege University Pediatric Genetics, Ege University" />
                <XRef ID="MONDO:0019234" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS214100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PEROXISOME BIOGENESIS DISORDER (NALD/IRD)</ElementValue>
                <XRef Type="MIM" ID="601539" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL</ElementValue>
                <XRef Type="MIM" ID="601539" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Peroxisome biogenesis disorders, Zellweger syndrome spectrum</ElementValue>
                <XRef ID="Peroxisome+biogenesis+disorders/5684" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALD: Adrenoleukodystrophy, X-Linked</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PBDS</ElementValue>
                <XRef ID="GTR000500811" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">PBD, ZSS</ElementValue>
                <XRef ID="NBK1448" DB="GeneReviews" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="11890" />
                <XRef ID="11890" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000501473" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501626" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501634" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501644" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520399" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525961" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000004880" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000028503" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000070509" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000318886" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501472" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501629" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501630" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501635" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000593050" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000028499" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000318975" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500811" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501466" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501474" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501625" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501628" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501631" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501647" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000070507" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000318883" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501632" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501633" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592488" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Zellweger spectrum disorder (ZSD) is a phenotypic continuum ranging from severe to mild. While individual phenotypes (e.g., Zellweger syndrome [ZS], neonatal adrenoleukodystrophy [NALD], and infantile Refsum disease [IRD]) were described in the past before the biochemical and molecular bases of this spectrum were fully determined, the term "ZSD" is now used to refer to all individuals with a defect in one of the ZSD-PEX genes regardless of phenotype. Individuals with ZSD usually come to clinical attention in the newborn period or later in childhood. Affected newborns are hypotonic and feed poorly. They have distinctive facies, congenital malformations (neuronal migration defects associated with neonatal-onset seizures, renal cysts, and bony stippling [chondrodysplasia punctata] of the patella[e] and the long bones), and liver disease that can be severe. Infants with severe ZSD are significantly impaired and typically die during the first year of life, usually having made no developmental progress. Individuals with intermediate/milder ZSD do not have congenital malformations, but rather progressive peroxisome dysfunction variably manifest as sensory loss (secondary to retinal dystrophy and sensorineural hearing loss), neurologic involvement (ataxia, polyneuropathy, and leukodystrophy), liver dysfunction, adrenal insufficiency, and renal oxalate stones. While hypotonia and developmental delays are typical, intellect can be normal. Some have osteopenia; almost all have ameleogenesis imperfecta in the secondary teeth.</Attribute>
                <XRef ID="NBK1448" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301621</ID>
                <ID Source="BookShelf">NBK1448</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2023">
                <URL>https://www.acmg.net/PDFLibrary/X-ALD-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated lysophosphatidylcholines, X-Linked Adrenoleukodystrophy (X-ALD), 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2023">
                <URL>https://www.acmg.net/PDFLibrary/X-ALD-Algorithm.pdf</URL>
                <CitationText>ACMG Algorithm, X-ALD: Elevated lysophosphatidylcholines C24:0, C26:0, 2023</CitationText>
              </Citation>
              <XRef ID="79189" DB="Orphanet" />
              <XRef ID="C1832200" DB="MedGen" />
              <XRef ID="MONDO:0019234" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS214100" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5461868" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000466.3:c.56_80del|OMIM:214100;234580;601539" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002804534" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000466.3:c.56_80del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="214100" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="234580" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="601539" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5504460" SubmissionDate="2023-01-11" DateLastUpdated="2023-01-15" DateCreated="2023-01-15">
        <ClinVarSubmissionID localKey="NM_000466.2:c.56_80del25|MedGen:C1832200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002819338" DateUpdated="2023-01-15" DateCreated="2023-01-15" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Variant summary: PEX1 c.56_80del25 (p.Val19AlafsX21) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 191070 control chromosomes. To our knowledge, no occurrence of c.56_80del25 in individuals affected with Zellweger Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000466.2:c.56_80del25</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1832200" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12529442</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7854070" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000466.3:c.56_80del|OMIM:234580" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004203291" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000466.3:c.56_80del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="234580" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4245668" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="12483057|MedGen:C0043459" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002236930" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9398847</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16086329</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16141001</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21031596</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26387595</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31831025</ID>
          </Citation>
          <Comment>ClinVar contains an entry for this variant (Variation ID: 1451521). This variant has not been reported in the literature in individuals affected with PEX1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Val19Alafs*21) in the PEX1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX1 are known to be pathogenic (PMID: 9398847, 16086329, 16141001, 21031596, 26387595, 31831025). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.92157670_92157694del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0043459" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5461868" TraitType="Disease" MappingType="XRef" MappingValue="234580" MappingRef="OMIM">
        <MedGen CUI="C4551980" Name="Heimler syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7854070" TraitType="Disease" MappingType="XRef" MappingValue="234580" MappingRef="OMIM">
        <MedGen CUI="C4551980" Name="Heimler syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5504460" TraitType="Disease" MappingType="XRef" MappingValue="C1832200" MappingRef="MedGen">
        <MedGen CUI="C1832200" Name="Peroxisome biogenesis disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5461868" TraitType="Disease" MappingType="XRef" MappingValue="601539" MappingRef="OMIM">
        <MedGen CUI="C0282527" Name="Peroxisome biogenesis disorder 1B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4245668" TraitType="Disease" MappingType="XRef" MappingValue="C0043459" MappingRef="MedGen">
        <MedGen CUI="C0043459" Name="Zellweger spectrum disorders" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5461868" TraitType="Disease" MappingType="XRef" MappingValue="214100" MappingRef="OMIM">
        <MedGen CUI="C4721541" Name="Peroxisome biogenesis disorder 1A (Zellweger)" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

